Abstract
Methods from causal inference are combined with established epidemiological techniques, to estimate population attribution fractions for the influence of smoking and BMI on the risk of 226 different diseases in UK Biobank. Simple expressions for population attribution fractions are derived for this purpose, and evaluated using estimates from proportional hazard models. These are compared to the attribution fractions used by the World Health Organisation. A counterfactual argument is used to determine an individual’s attribution fraction Af in terms of proportional hazard estimates, finding Af = 1 − 1/R, where R is an individual’s relative risk. It is emphasised that causally meaningful attribution fractions cannot be constructed for all known risk factors or confounders, but there are important cases where they can. This includes the causal model that is assumed here to describe the influence of smoking and BMI on disease risk. The causal attribution of smoking and BMI to incidence of disease is summarised in terms of disease chapters from the International Classification of Diseases (ICD-10), and the diseases most strongly attributed to smoking and BMI are identified. The result is a quantitative characterisation of the causal influence of smoking and BMI on the landscape of disease incidence in the UK Biobank population.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research was funded by a fellowship from the Nuffield Department of Population Health, University of Oxford.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study uses UK Biobank data, that is available by application from: www.ukbiobank.ac.uk
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
The paper was reorganised, and the title and abstract modified to account for this.
Data Availability
The study uses UK Biobank data, that is available by application from: www.ukbiobank.ac.uk
